S&P・Nasdaq 本質的価値 お問い合わせ

SciSparc Ltd. SPRC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score
31/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

SciSparc Ltd. (SPRC) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $0.03 および 売上高 $6.97B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-1.08 vs 予想 $0.03 (下回る -3655%). アナリスト精度: 0%.

EPS予測 — SPRC

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$1.08 vs Est $0.03 ▼ 102.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

売上高予測 — SPRC

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $0.001B vs Est $6.972B ▼ 533,750.9% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る